Newsroom

2026

2026-05-27 09:00 Lumito awarded Vinnova funding to strengthen regulatory and quality capabilities during commercialisation Regulatory

2026-05-25 14:15 Subscription price for the exercise of warrants of series TO7 in Lumito AB has been set at 3.5 SEK per share, and the exercise period begins today, 25 May 2026 Regulatory

2026-05-07 08:30 Lumito AB publishes Interim Report Q1 2026 Regulatory MAR

2026-05-05 11:00 Invitation to webinar in connection with Lumito AB’s interim report for Q1 2026 Regulatory

2026-05-04 10:00 Simpler biomarker workflows without compromising sensitivity: new white paper shows how researchers gain reproducible, quantitative IHC results in fewer steps Regulatory

2026-04-09 08:30 Lumito’s CRO strategy generates revenue through collaboration with Truly Labs AB Regulatory

2026-04-02 08:30 Lumito and OracleBio initiate a pilot project to explore the combination of high-sensitivity tissue imaging and advanced image analysis Regulatory

2026-03-18 09:00 Lumito and Tethis complete proof-of-concept study demonstrating compatibility between Lumito’s UCNP imaging and Tethis’ SmartBioSurface® slides Regulatory

2026-03-12 09:15 Lumito and Offspring Biosciences initiate pilot study to combine automated, standardised workflows with high‑sensitivity tissue analysis Regulatory

2026-03-10 15:15 Analyst Group publishes equity research report on Lumito Regulatory